東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Clinical trials in the neurosciences

Woodbury-Harris, K. M.

FindBook

Google Book

Amazon

博客來

Clinical trials in the neurosciences

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Clinical trials in the neurosciences/ volume editors, K.M. Woodbury-Harris, B.M. Coull.{me_controlnum}
其他作者:	Woodbury-Harris, K. M.
出版者:	Basel :S. Karger, : 2009,
面頁冊數:	1 online resource :ill. (some col.)
附註:	A comprehensive and practical overview
標題:	Neurology - Research. -
電子資源:	http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=242160
ISBN:	9783805590242

Clinical trials in the neurosciences
Clinical trials in the neurosciences[electronic resource] /volume editors, K.M. Woodbury-Harris, B.M. Coull.{me_controlnum} - Basel :S. Karger,2009 - 1 online resource :ill. (some col.) - Frontiers of Neurology and Neuroscience,v.251662-2804 ;. - Frontiers of neurology and neuroscience ;v.25..

A comprehensive and practical overview

Includes bibliographical references and indexes.

A properly designed and executed clinical trial that addresses an import question and delivers a definitive result can change the practice of medicine worldwide. This book encompasses a bench-to-bedside approach and serves as an excellent guidance for translating preclinical studies to early phase I/II and phase III trials. In the first part, the book covers preclinical science with respect to animal models of various neurological diseases, FDA requirements for preclinical studies, translation of animal to patient studies and scaling up from animal to human studies. In the second part, the design of phase I/II trials and the use of biomarkers as surrogate endpoints are discussed. With regard to phase III trials, FDA and European requirements, specific design issues, relevant clinical endpoints as well as data management and quality are examined. Topics specific to multicenter trials, such as design, recruitment of special populations, monitoring, ethical and consent issues are also covered. Finally, genetics, gene therapy, imaging and surgical devices are reviewed.This publication is highly recommended to clinician researchers, such as neurologists, neurosurgeons, pediatric neurologists and neonatologists, who want to design and conduct clinical trials in the neuroscience, but also to nurses, research coordinators and clinical pharmacologists.

ISBN: 9783805590242Subjects--Topical Terms:

1360698
Neurology
--Research.

LC Class. No.: RC337 / .C63 2009

Dewey Class. No.: 616.80072/4

National Library of Medicine Call No.: W1 / MO568C v.25 2009

Clinical trials in the neurosciences
LDR:02334cmm a2200265 a 4500 001 1032429
003 SZ-BaSKA
005 20110603112133.0
006 m d
007 cr cnu---unuuu
008 120420s2009 sz a ob 001 0 eng d
020 $a 9783805590242
035 $a 242160
040 $a szbaska
050 0 0 $a RC337 $b .C63 2009
060 0 0 $a W1 $b MO568C v.25 2009
060 1 0 $a WL 100 $b C6439 2009
082 0 0 $a 616.80072/4 $2 22
245 0 0 $a Clinical trials in the neurosciences $h [electronic resource] / $c volume editors, K.M. Woodbury-Harris, B.M. Coull.{me_controlnum}
260 $a Basel : $b S. Karger, $c 2009
300 $a 1 online resource : $b ill. (some col.)
490 1 $a Frontiers of Neurology and Neuroscience, $x 1662-2804 ; $v v.25
500 $a A comprehensive and practical overview
504 $a Includes bibliographical references and indexes.
520 $a A properly designed and executed clinical trial that addresses an import question and delivers a definitive result can change the practice of medicine worldwide. This book encompasses a bench-to-bedside approach and serves as an excellent guidance for translating preclinical studies to early phase I/II and phase III trials. In the first part, the book covers preclinical science with respect to animal models of various neurological diseases, FDA requirements for preclinical studies, translation of animal to patient studies and scaling up from animal to human studies. In the second part, the design of phase I/II trials and the use of biomarkers as surrogate endpoints are discussed. With regard to phase III trials, FDA and European requirements, specific design issues, relevant clinical endpoints as well as data management and quality are examined. Topics specific to multicenter trials, such as design, recruitment of special populations, monitoring, ethical and consent issues are also covered. Finally, genetics, gene therapy, imaging and surgical devices are reviewed.This publication is highly recommended to clinician researchers, such as neurologists, neurosurgeons, pediatric neurologists and neonatologists, who want to design and conduct clinical trials in the neuroscience, but also to nurses, research coordinators and clinical pharmacologists.
650 0 $a Neurology $x Research. $3 1360698
650 0 $a Neurosciences $x Research. $3 783155
650 0 $a Clinical trials. $3 724498
650 1 2 $a Clinical Trials as Topic. $3 1074953
650 1 2 $a Neurology $x methods. $3 915245
650 2 2 $a Nervous System Diseases. $3 604189
650 2 2 $a Neurosurgical Procedures. $3 1360699
650 2 2 $a Research Design. $3 709476
700 1 $a Woodbury-Harris, K. M. $q (Katherine M.) $3 1360695
700 1 $a Coull, B. M. $q (Bruce M.) $3 1360696
830 0 $a Frontiers of neurology and neuroscience ; $v v.25. $3 1360697
856 4 0 $u http://content.karger.com/ProdukteDB/produkte.asp?Aktion=showproducts&searchWhat=books&searchParm=toc&ProduktNr=242160